share_log
Reuters ·  May 1 21:31
Astellas Pharma: Poseida Will Receive US $50 Million Upfront Plus Potential Development and Sales Milestones
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment